Fladgate LLP has advised Bluewater Bio International (Bluewater Bio), a provider of innovative high-performance and highly cost-effective water and wastewater treatment technologies, on a £22.5 million equity financing round. The transaction was led by specialist cleantech investors Ombu Group and Hermes GPE Environmental Innovation Fund LP.
The board of Bluewater Bio believes that this transaction represents one of the largest growth capital finance rounds in the water sector over the last 12 months and reflects the Company’s recent commercial progress.
The Fladgate team was led by corporate partner David Robinson, assisted by Linda Whittle (corporate solicitor), Naomi Oppenheim (employment solicitor) and Adrian Mawlabaux (chartered legal executive).
Commenting on the transaction, David Robinson said: “Bluewater Bio is a long-standing client of the firm, and we are delighted that it has achieved funding on this scale. We look forward to helping the company evolve over the coming years into a substantial water and wastewater solutions business”.
Fladgate has in-depth knowledge of the energy and resources sector, drawing upon extensive legal expertise and broad industry experience to advise on a wide variety of domestic and international transactions. The cross firm team comprises experienced practitioners in the fields of corporate finance, commercial contracts, mergers and acquisitions and projects, with sector specific knowledge in a range of areas including cleantech, energy, oil and gas, mining and renewables.